Who is sponsoring NCT05761691?

NCT05761691 is sponsored by Riyadh Elm University.

What drugs are being tested in NCT05761691?

Interventions in NCT05761691: Dental treatment.

What condition does NCT05761691 study?

NCT05761691 studies Oral Health Related Quality of Life OHRQoL.

Is NCT05761691 still recruiting?

NCT05761691 is currently completed. Last updated 14 March 2023.

Last reviewed 2023-03-14 · How we verify

NCT05761691

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Does Treating Early Childhood Caries Under Local or General Anesthesia Have Varying Effects on OHRQoL

Completed NA Last updated 14 March 2023

What this trial tests

NA trial testing Dental treatment in Oral Health Related Quality of Life OHRQoL in 73 participants. Completed in 1 March 2022.

Timeline

1 February 2021

Primary endpoint
1 January 2022

1 March 2022

Quick facts

Lead sponsor	Riyadh Elm University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	73
Start date	1 February 2021
Primary completion	1 January 2022
Estimated completion	1 March 2022
Sites	1 location across Saudi Arabia

Drugs / interventions tested

Dental treatment

Conditions studied

Oral Health Related Quality of Life OHRQoL — all drugs for Oral Health Related Quality of Life OHRQoL →

Sponsor

Riyadh Elm University

Who can join

Adults 2 to 6, any sex, with Oral Health Related Quality of Life OHRQoL. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A two-arm randomized control trial is to compare the changes in OHRQoL scores among children treated for ECC under general (DGA) and local anesthesia (LA). Outcome variable was OHRQoL, measured using the early childhood oral health impact scale ECOHIS and explanatory variable was the administration of local or general anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dental treatment

Trials testing the same drug.

NCT04967300 — Measuring and Evaluating the Changes in Anxiety Levels of Children With Repetitive Sessions of Dental Treatments · completed
NCT03520309 — Clinical Criteria for the Evaluation of Caries Lesions Around Restorations in Primary Teeth (CARDEC-03) · NA · completed
NCT03108586 — Caries Cognition and Identification in Adults · NA · active not recruiting

Other Riyadh Elm University trials

Trials by the same sponsor.

NCT07397871 — Salivary Flow, pH, and Buffering Capacity in Fixed and Clear Aligner Orthodontic Treatment · NA · not yet recruiting
NCT06503029 — Evaluate Cytotoxicity, Leaching, and Structural Conformation of Clear Aligners · Phase 4 · not yet recruiting
NCT06161714 — The Effectiveness of Buccal Infiltration Only Using Articaine for Extraction of Mandibular Molar · Phase 4 · unknown
NCT06093256 — Taste Changes With Fixed Orthodontic Appliances · unknown
NCT06790433 — Comparison Between the Dentapen and Vibraject · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05761691 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Riyadh Elm University
Last refreshed: 14 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05761691.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing